Burroughs Wellcome Fund Archives
Anti-nausea drug response in children
Jan. 10, 2023—Genetic variation in a metabolic enzyme was not associated with response to the anti-nausea drug odansetron in children, Vanderbilt researchers report.
Vanderbilt researchers discover how gut inflammation leads to bone loss
Aug. 25, 2022—Gastrointestinal inflammation, such as occurs in inflammatory bowel disease, triggers the expansion of a population of “bone-eating” cells, leading to bone loss.
Nanoparticles boost anti-cancer immunity
Aug. 16, 2022—An ingenious targeted nanoparticle approach developed by Vanderbilt researchers reduced tumor burden in a model of ovarian cancer.
Bacterial battle in 3D
Jun. 2, 2022—Using imaging mass spectrometry and microscopy, Vanderbilt researchers visualized how staph bacteria modifies lipids in its membrane to evade immune system-mediated killing.
A clue to an adverse drug event in children
May. 19, 2022—Considering metabolic (CYP2D6) enzyme activity score and patient age may aid in determining an individual’s risk for an adverse event with administration of the anti-arrhythmic drug propafenone.
Youthful healing for burn wounds
Apr. 21, 2022—Topical treatment of burns with an immunosuppressive drug counteracted the negative effects of aging on wound healing, Vanderbilt researchers have discovered.
Two VUMC physician-scientists win Burroughs Wellcome Fund Career Awards
Jun. 21, 2021—Two physician-scientist Instructors in Medicine at Vanderbilt University Medical Center (VUMC) — Jeeyeon Cha, MD, PhD, and Celestine Wanjalla, MD, PhD — are among 12 recipients of the 2021 Burroughs Wellcome Fund (BWF) Career Award for Medical Scientists.
HBCU scholars program expanding enrollment
Mar. 11, 2021—The James Puckette Carter Scholars Program, the result of a partnership between Meharry Medical College (MMC), Vanderbilt University Medical Center and the Burroughs Wellcome Fund (BWF), intended to increase the number of physicians who attended Historically Black Colleges and Universities (HBCUs) in health care, is expanding to double its enrollment capacity.
Grant helps expand VI4’s Artist-in-Residence program
Oct. 29, 2020—An innovative Vanderbilt program that brings together scientists and artists with the shared goal of scientific communication is set to expand with support from a three-year grant from the Burroughs Wellcome Fund.
Bick receives Burroughs Wellcome Fund Career Award for Medical Scientists
Sep. 3, 2020—Alexander Bick, MD, PhD, assistant professor of Medicine in the Division of Genetic Medicine at Vanderbilt University Medical Center, is a recipient of the 2020 Burroughs Wellcome Fund (BWF) Career Award for Medical Scientists.
Study explores how staph bacteria can survive in bone
Jun. 3, 2020—A comprehensive evaluation of the metabolic pathways that support Staphylococcus aureus (“staph”) growth during invasive bone infections could offer new targets for treatment.
Tailoring treatment for heart defect
Sep. 23, 2019—By defining the clinical and genetic factors that predict treatment response, Vanderbilt investigators aim to personalize therapy for a common heart complication in preterm infants.